業績(2025まで) / 最近 / preprint/submit/revision
revision (3月6日時点で合計6報)
- Yamamoto H, Suzuki H, Tanaka T, Kaneko MK, Kato Y.
Development of highly sensitive and specific monoclonal antibodies against Glypican-1 using the cell-based immunization and screening technology
ijtm-4200937, 2026 (PDF; preprint; YouTube)
- Yamamoto H, Suzuki H, Kaneko MK, Kato Y.
A novel anti-CDH5/VE-cadherin monoclonal antibody (Ca5Mab-8) for flow cytometry, Western blotting, and immunohistochemistry
MAB-2026-0005, 2026 (PDF; preprint)
- Li G, Suzuki H, Kaneko MK, Kato Y.
A novel anti-Cadherin 19 monoclonal antibody (Ca19Mab-8) for flow cytometry, Western blotting, and immunohistochemistry
cimb-4183612, 2026 (PDF; preprint)
- Li G, Suzuki H, Ohishi T, Satofuka H, Ishikawa K, Shimizu K, Nomura A, Araki H, Kojo N, Suzuki K, Handa S, Nakamura T, Yanaka M, Tanaka T, Kaneko MK, Kato Y.
Antitumor activities of chimeric anti-EphA2 antibodies in xenograft models of breast, pancreatic, and colorectal cancers
ijms-4165400, 2026 (PDF; preprint)
- Horikawa T et al.,
In vitro characterization of an equinized anti-PD-L1 antibody for cancer immunotherapy in horses
Veterinary Sciences, 2026
- Ishii Y et al.,
MAT2A and S-adenosylmethionine are required for B cell activation through histone methylation
EMBO Molecular Medicine, 2026
submit (3月6日時点で合計8報)
- Okuno S, Suzuki H, Kaneko MK, Kato Y.
A Novel Anti-Glypican-3 Monoclonal Antibody G3Mab-25 for Flow Cytometry, Western Blotting, and Immunohistochemistry
MAB-2026-0007, DOI:10.20944/preprints202510.2209.v1, 2026 (PDF; preprint; YouTube)
- Yamamoto H, Suzuki H, Ohishi T, Satofuka H, Kaneko MK, Kato Y.
Chimeric anti-Glypican 1 antibodies exert antitumor activities in xenograft models of lung and pancreatic cancers.
ijms-4180204, 2026 (PDF; preprint)
- Kim et al.,
Multivalent Peptide Nanotherapeutics Achieve Potent Epidermal Growth Factor Receptor Blockade and Tumor Growth Suppression
Nano Letters, 2026
- Nakamura et al.,
Exhausted CD4+T cells are associated with CCL4-driven immunosuppressive macrophage accumulation in enzootic bovine leukosis
Frontiers in Immunology, 2026
- Suzuki et al.,
Near-infrared photoimmunotherapy targeting canine mammary tumors: comparative oncology for overcoming human breast cancer
SREP, 2026
- Izumi, et al.,
Development of a Standalone Anti-PDPN CasMab CAR-T Cell Product with Tumor Specificity and Robust Antitumor Activity
Genes and Cells, 2026
- Honma et al.,
Dynamic Expression of Podoplanin Correlates with Synovitis Severity in a Lipopolysaccharide-Induced Rabbit Arthritis Model
TJEM, 2026
- Pan et al.,
CXCR6 Blockade Is a Powerful Therapy for Immune Checkpoint Inhibitor-induced Myocarditis
ACS Nano Medicine, 2026
preprint (2月27日時点で合計2報)
- Ishikawa K, Suzuki H, Ohkoshi A, Kaneko MK, Katori Y, Kato Y.
G2Mab-7: an anti-Glypican-2 monoclonal antibody for versatile applications
Preprint, 2026 (PDF; preprint)
- Nakamura T, Shinoda K, Suzuki H, Kaneko MK, Kato Y.
A novel anti-Cadherin 8 monoclonal antibody, Ca8Mab-4, for versatile applications
Preprint, 2026 (PDF; preprint)
業績(2025まで) / 最近 / preprint/submit/revision
業績
業績検索
